For instance, the most recurrently observed nullomer was found at BRAF across 5.5% of cancer patients, while other top emerging nullomers were found at individual loci in IDH1, PIK3CA, KRAS and TP53 (Table 1), all of which are known cancer genes. The gene discussed is TP53; the disease is cancer.